Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04612400 · ClinicalTrials.gov registry record · NA
Whole Body Protein Metabolism of a Whey/EAA Supplement Using Continuous Oral Stable Isotopes
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04612400: Completed NA study, sponsored by University of Arkansas.
NCT04612400 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04612400, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
To evaluate the validity of a continuous oral sip-feeding method of stable isotope tracer for the evaluation of whole-body protein metabolism in response to two different doses of an EAA/whey protein supplement (Low=6.3g and High=12.6g). Results will be compared to those previously determined by constant infusion with the same EAA/whey supplement.
Primary Outcome
grams of protein per 240 minutes as determined using stable isotope ingestion and blood analysis for said isotopes' concentrations.
Interventions
- OTHER Oral amino acid tracer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-11-04 |
| Est. Completion | 2021-09-06 |
| Phase | NA |
What the finished NCT04612400 record still lists
NCT04612400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Oral amino acid tracer is the first listed.
NCT04612400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04612400 about?
NCT04612400 is a clinical study titled "Whole Body Protein Metabolism of a Whey/EAA Supplement Using Continuous Oral Stable Isotopes". To evaluate the validity of a continuous oral sip-feeding method of stable isotope tracer for the evaluation of whole-body protein metabolism in response to two different doses of an EAA/whey protein supplement (Low=6.3g and High=12.6g). Results will be compared to those previously determined by con...
What is the current status of trial NCT04612400?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2020-11-04. Estimated completion is 2021-09-06.
What interventions are being tested in trial NCT04612400?
The interventions under investigation include: Oral amino acid tracer (OTHER).
Who is sponsoring clinical trial NCT04612400?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04612400's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI